Top Markets
Coin of the day
Nanomix Corporation Nanomix Corporation

Nanomix Corporation

NNMX
Classificação em ações #41810
Boston Therapeutics, Inc. focuses on the discovery, production, and... Boston Therapeutics, Inc. focuses on the discovery, production, and commercialization of therapeutic drugs aimed at fulfilling critical unmet medical needs in the areas of diabetes and inflammatory diseases. The company's pipeline features BTI-320, a non-systemic, carbohydrate-based tablet currently in Phase II clinical trials, which is being developed to reduce post-meal blood glucose levels in patients with pre-diabetes and type 2 diabetes. They also have IPOXYN, an injectable medication designed to prevent tissue necrosis and address conditions caused by low oxygen, such as diabetic foot ulcers and other related vascular or neurological complications. Additionally, Boston Therapeutics is progressing with BTI-410, a peptide injectable compound also in Phase II clinical development, intended to stimulate beta cell maturation in the pancreas. This could potentially serve as a new insulin-producing cell agent for individuals with type 2 diabetes and type 1 patients on immunosuppression therapy following a kidney transplant. Complementing its pharmaceutical endeavors, the company offers SUGARDOWN, a non-systemic, polysaccharide-based dietary supplement designed to support healthy blood glucose management, and OXYFEX, a veterinary application that acts as an oxygen delivery agent, similar to a red blood cell replacement, for treating ischemia, trauma, and blood loss during surgical procedures. The firm further extends its offerings to include Automatic Retinal Image Analysis (ARIA), a diagnostic tool used for screening cardiovascular risks, including stroke. Boston Therapeutics, Inc. maintains its headquarters in Lawrence, Massachusetts.
Preço da ação
$0.0002
Última sincronização: 2025-04-08
Valor de mercado
$9.80K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Nanomix Corporation (NNMX)

Categoria

Preço NNMX com a capitalização de mercado de B
Nanomix Corporation Nanomix Corporation
NNMX
$0.0002
Capitalização de mercado de Nanomix Corporation(NNMX)
Valor de mercado: $9.80K
Em August 2026, Nanomix Corporation tem uma capitalização de mercado de $9.80K. Isso faz com que Nanomix Corporation seja a 41810th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Nanomix Corporation de 2021 a 2026
NNMX comparado com o topo de 5 mais populares stocks
Preço para NNMX Ativo B Capitalização de mercado de B Resultados
Nanomix Corporation Nanomix Corporation
$109,876 $9.80K
$5.383T +54,937,845,190.34%
Nanomix Corporation Nanomix Corporation
$90,282.50 $9.80K
$4.423T +45,141,251,086.22%
Nanomix Corporation Nanomix Corporation
$84,914.16 $9.80K
$4.160T +42,457,081,225.46%
Nanomix Corporation Nanomix Corporation
$74,769.28 $9.80K
$3.663T +37,384,639,526.49%
Nanomix Corporation Nanomix Corporation
$59,010.69 $9.80K
$2.891T +29,505,345,296.47%